Xiaomei Guo
1095 Jiefang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Intravascular ultrasound-guided percutaneous coronary intervention in acute coronary syndrome stratified by the TVF-ACS risk score: the IVUS-ACS trial.
Journal: European heart journal open
Published: September 23, 2025
Efficacy and safety of bevifibatide in patients with acute coronary syndrome undergoing percutaneous coronary intervention (BES-PCI): A multicenter, randomized, double-blinded, placebo-controlled, phase III trial.
Journal: Chinese medical journal
Published: May 15, 2025
Efficacy and Safety of a Generic Clevidipine in Hypertensive Urgencies and Non-Fulminant Hypertensive Emergencies: A Phase III, Multicenter, Randomized, Double-Blind, Positive Drug Parallel-Controlled Study.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: May 12, 2025
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.
Journal: Lancet (London, England)
Published: January 24, 2024
Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-κB-dependent cardiomyocyte pyroptosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 24, 2023
A facile near-infrared xanthene fluorescence probe for visualizing of hypochlorous acid in vitro and in vivo.
Journal: Analytica chimica acta
Published: August 03, 2023
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: July 17, 2023
Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis.
Journal: Science China. Life sciences
Published: March 21, 2023
Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: October 04, 2022
Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial.
Journal: JACC. Cardiovascular interventions
Published: July 29, 2022
Last Updated: 09/26/2026